Download PDF
Dtsch Med Wochenschr 2013; 138(16): 837-841
DOI: 10.1055/s-0032-1332982
Übersicht | Review article
Pneumologie, Telemedizin
© Georg Thieme Verlag KG Stuttgart · New York

Die akute Exazerbation der COPD

Kann die Telemedizin einen Beitrag zur Früherkennung leisten?Telemonitoring in patients with COPD and acute exacerbations
U. Koehler
1   SP Pneumologie, Intensiv- und Schlafmedizin, Klinik für Innere Medizin, Philipps-Universität Marburg
,
T. Greulich
1   SP Pneumologie, Intensiv- und Schlafmedizin, Klinik für Innere Medizin, Philipps-Universität Marburg
,
V. Gross
2   SP Biomedizinische Technik, Fachbereich Krankenhaus- und Medizintechnik, Umwelt- und Biotechnologie (KMUB), Technische Hochschule Mittelhessen, Gießen
,
O. Hildebrandt
1   SP Pneumologie, Intensiv- und Schlafmedizin, Klinik für Innere Medizin, Philipps-Universität Marburg
,
F. Redhardt
1   SP Pneumologie, Intensiv- und Schlafmedizin, Klinik für Innere Medizin, Philipps-Universität Marburg
,
K. Sohrabi
3   Fachbereich MNI, Medizinische Informatik, Technische Hochschule Mittelhessen, Gießen
,
A. Weissflog
2   SP Biomedizinische Technik, Fachbereich Krankenhaus- und Medizintechnik, Umwelt- und Biotechnologie (KMUB), Technische Hochschule Mittelhessen, Gießen
,
R. Koczulla
1   SP Pneumologie, Intensiv- und Schlafmedizin, Klinik für Innere Medizin, Philipps-Universität Marburg
› Author Affiliations
Further Information

Publication History

14 September 2012

10 December 2012

Publication Date:
15 April 2013 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Früherkennung von Exazerbationen könnte ein entscheidender Ansatzpunkt bei der telemedizinischen Überwachung von Patienten mit COPD sein. Akute Exazerbationen sind von großer klinischer und ökonomischer Relevanz, weil sie zu einer vermehrten stationären Behandlungsnotwendigkeit, einem Verlust an noch funktionsfähigem Lungenparenchym, einer eingeschränkten Lebensqualität sowie einer signifikant erhöhten Mortalität führen. Eine frühzeitige Diagnostik könnte eine richtungsweisende medikamentöse Therapie initiieren und stationäre Aufenthalte verhindern. Ob die telemedizinische Überwachung von Patienten mit COPD und die frühzeitige Erkennung einer Exazerbation tatsächlich eine nachhaltige Verbesserung der Patientenversorgung und der Kostenstruktur mit sich bringen können, ist bislang jedoch nicht geklärt.

Abstract

A major problem associated with COPD is exacerbation. Symptoms include increased shortness of breathing, coughing, wheezing and sputum production. The frequency and severity of exacerbations are associated with a higher mortality risk. Early recognition and treatment have been shown to reduce severity of exacerbations, consecutive morbidity and hospital admissions. Telemonitoring of (nocturnal) lungsounds, oxygen saturation and frequency of breathing may offer the opportunity to detect symptoms of exacerbations very early. Therefore further research is needed to clarify precisely the role of telemonitoring in patients with COPD and exacerbations.

Schlüsselwörter

chronisch obstruktive Lungenkrankheit (COPD) - Exazerbation - Telemedizin

Keywords

chronic obstructive pulmonary disease (COPD) - exacerbation - telemedicine
 

  • Literatur

  • 1 Aaron SD, Donaldson GC, Whitmore GA et al. Time course and pattern of COPD exacerbation onset. Thorax 2012; 67: 238-243
    CrossrefPubMedGoogle Scholar
  • 2 Augusti A, Hedner J, Marin JM et al. Night-time symptoms: a forgotten dimension of COPD. Eur Respir Rev 2011; 20: 183-194
    CrossrefPubMedGoogle Scholar
  • 3 Bischoff EW, Hamd DH, Sedeno M et al. Effects of written action plan adherence on COPD exacerbation recovery. Thorax 2011; 66: 26-31
    CrossrefPubMedGoogle Scholar
  • 4 Bossenbroek L, de Greef MH, Wempe JB et al. Daily physical activity in patients with chronic obstructive pulmonary disease: a systematic review. COPD 2011; 8: 306-319
    CrossrefPubMedGoogle Scholar
  • 5 Bucknall CE, Miller G, Lloyd SM et al. Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: randomised controlled trial. BMJ 2012; 344: 1-13
    PubMedGoogle Scholar
  • 6 Burgel PR. Chronic cough and sputum production: a clinical COPD phenotype?. Eur Respir J 2012; 40: 4-6
    CrossrefPubMedGoogle Scholar
  • 7 Celli BR, Barnes PJ. Exacerbations of chronic obstructive pulmonary disease. Eur Respir J 2007; 29: 1224-1238
    CrossrefPubMedGoogle Scholar
  • 8 Celli BR, Vestbo J. The Exact-Pro: Measuring Exacerbations of COPD. Am J Respir Crit Care Med 2011; 183: 287-288
    CrossrefPubMedGoogle Scholar
  • 9 de Vries M, Berendsen AJ, Bosveld HE et al. COPD exacerbations in general practice: variability in oral prednisolone courses. BMC Fam Pract 2012; 13: 3-10
    CrossrefPubMedGoogle Scholar
  • 10 Donaldson GC, Wilkinson TM, Hurst JR et al. Exacerbations and time spent outdoors in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005; 171: 446-452
    CrossrefPubMedGoogle Scholar
  • 11 Fabbri LM, Beghe B, Agust A. Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelines. Thorax 2011; 66: 745-747
    CrossrefPubMedGoogle Scholar
  • 12 Fähndrich S, Guttmann C, Bals R. Chronische obstruktive Lungenerkrankung: Pathophysiologie, Diagnostik und Therapie. Dtsch Med Wochenschr 2011; 136: 1847-1860
    Article in Thieme ConnectPubMedGoogle Scholar
  • 13 Fan VS, Gaziano JM, Lew R et al. A comprehensive care management program to prevent chronic obstructive pulmonary disease hospitalization – a randomized, controlled trial. Ann Intern Med 2012; 156: 673-683
    CrossrefPubMedGoogle Scholar
  • 14 Garcia-Rio F, Rojo B, Casitas R et al. Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest 2012; 142: 338-346
    CrossrefPubMedGoogle Scholar
  • 15 Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic pulmonary disease. http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013Feb13.pdf
    Google Scholar
  • 16 Greulich T, Kozculla R, Vogelmeier C et al. Die chronisch obstruktive Lungenerkrankung (COPD) als Systemerkrankung. Dtsch Med Wochenschr 2009; 134: 1231-1235
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Guerra S, Sherrill DL, Venker C et al. Chronic bronchitis before age 50 years predicts incident airflow limitation and mortality risk. Thorax 2009; 64: 894-900
    CrossrefPubMedGoogle Scholar
  • 18 Hurst JR, Donaldson GC, Perera WR et al. Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 174: 867-874
    CrossrefPubMedGoogle Scholar
  • 19 Hurst JR, Vestbo J, Anzueto A et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010; 363: 1128-1138
    CrossrefPubMedGoogle Scholar
  • 20 Jones PW, Chen WH, Wilcox TK et al. Characterizing and quantifying the symptomatic features of COPD exacerbations. Chest 2011; 139: 1388-1394
    CrossrefPubMedGoogle Scholar
  • 21 Karg O, Weber M, Bubulj C et al. Akzeptanz einer telemedizinischen Intervention bei Patienten mit chronisch obstruktiver Lungenerkrankung. Dtsch Med Wochenschr 2012; 137: 574-579
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Kessler R, Partridge MR, Miravitlles M et al. Symptom variability in patients with severe COPD : a pan-European cross-sectional study. Eur Respir J 2011; 37: 264-272
    CrossrefPubMedGoogle Scholar
  • 23 Kim V, Han ML, Vance GB et al. The chronic bronchitis phenotype of COPD. An analysis of the COPD Gene Study. Chest 2011; 140: 626-633
    CrossrefPubMedGoogle Scholar
  • 24 Koehler U, Hildebrandt O, Koehler KI et al. Is the telemedical management of COPD patients of any value?. Pneumologie 2012; 66: 302-304
    Article in Thieme ConnectPubMedGoogle Scholar
  • 25 Leidy NK, Wilcox TK, Jones PW et al. Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary. Am J Respir Crit Care Med 2011; 183: 323-3299
    CrossrefPubMedGoogle Scholar
  • 26 Matkovic Z, Huerta A, Soler N et al. Predictors of adverse outcome in patients hospitalised for exacerbation of chronic obstructive pulmonary disease. Respiration 2012; 84: 17-26
    CrossrefPubMedGoogle Scholar
  • 27 McLean S, Nurmatov U, Liu JL et al. Telehealthcare for chronic obstructive pulmonary disease (Review). Cochrane Libr 2011; 7: 1-51
    PubMedGoogle Scholar
  • 28 Patridge MR, Karlsson N, Small IR. Patient insight into the impact of chronic obstructive pulmonary disease in the morning: an internet survey. Curr Med Res Opin 2009; 25: 2043-2048
    CrossrefPubMedGoogle Scholar
  • 29 Perera WR, Hurst JR, Wilkinson TM et al. Inflammatory changes, recovery and recurrence at COPD exacerbation. Eur Respir J 2007; 29: 527-534
    CrossrefPubMedGoogle Scholar
  • 30 Polisena J, Tran K, Cimon K et al. Home telehealth for chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Telemed Telecare 2010; 16: 120-127
    CrossrefPubMedGoogle Scholar
  • 31 Rosenberg SR, Kalhan R. Biomarkers in chronic obstructive pulmonary disease. Transl Res 2012; 159: 228-237
    CrossrefPubMedGoogle Scholar
  • 32 Seemungal TA, Donaldson GC, Bhowmik A et al. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1608-1613
    CrossrefPubMedGoogle Scholar
  • 33 Seemungal TA, Hurst JR, Wedzicha JA. Exacerbation rate, health status and mortality in COPD – a review of potential interventions. Int J Chron Obstruct Pulmon Dis 2009; 4: 203-223
    PubMedGoogle Scholar
  • 34 Seemungal TA, Wedzicha JA. Acute exacerbations of COPD: the challenge is early treatment. COPD 2009; 6: 79-81
    CrossrefPubMedGoogle Scholar
  • 35 Singh JM, Palda VA, Stanbrook MB et al. Corticosteroids Therapy for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Arch Intern Med 2002; 162: 2527-2536
    CrossrefPubMedGoogle Scholar
  • 36 Soler-Cataluna JJ, Martinez-Garcia MA, Roman Sanchez P et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005; 60: 925-931
    CrossrefPubMedGoogle Scholar
  • 37 Stone RA, Lowe D, Potter JM et al. Managing patients with COPD exacerbation: does age matter?. Age Ageing 2012; 41: 461-468
    CrossrefPubMedGoogle Scholar
  • 38 Vittaca M, Bianchi L, Guerra A et al. Tele-assistance in chronic respiratory failure patients: a randomised clinical trial. Eur Resp J 2009; 33: 411-418
    PubMedGoogle Scholar
  • 39 Wan ES, DeMeo DL, Hersh CP et al. Clinical predictors of frequent exacerbations in subjects with severe chronic obstructive pulmonary disease (COPD). Respir Med 2011; 105: 588-594
    CrossrefPubMedGoogle Scholar
  • 40 Wilkinson TM, Donaldson GC, Hurst JR et al. Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 169: 1298-1303
    CrossrefPubMedGoogle Scholar
  • 41 Yanez AM, Guerrero D, Perez de Alejo R et al. Monitoring breathing rate at home allows early identification of COPD exacerbations. Chest 2012; Epub ahead of print
    PubMedGoogle Scholar